KDM3A knockdown regulates COMP, LOX, COL8A1 and ACOT1 genes in myocardial fibrosis

Abrar A Alzhrani1, Mahmood Rasool2, Sajjad Karim2

  • 1Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.

Bioinformation
|June 10, 2024
PubMed

Insights

This study identifies key genes like COMP, COL8A1, and LOX involved in heart failure development. Overexpression of KDM3A promotes cardiac fibrosis and heart failure by altering these gene expressions.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genomics

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in Saudi Arabia.
  • Cardiac remodeling is central to heart failure pathophysiology.
  • Identifying genes in pathological cardiac remodeling is crucial.

Purpose of the Study:

  • To identify critical genes implicated in pathological cardiac remodeling.
  • To investigate the role of lysine-specific demethylase 3A (KDM3A) in cardiac fibrosis.
  • To explore potential therapeutic targets for heart failure.

Main Methods:

  • Analysis of microarray data (GSE120739) from the Gene Expression Omnibus (GEO) database.
  • Utilized in-silico tools: GEO2R, Metascape, WebGestalt, and Ingenuity Pathway Analysis (IPA).
  • Investigated gene expression changes related to extracellular matrix and fatty acid metabolism pathways.

Main Results:

  • Knockdown of KDM3A led to downregulation of extracellular matrix genes (COMP, COL8A1, LOX).
  • Acyl-CoA thioesterase 1 (ACOT1) was upregulated under KDM3A knockdown.
  • KDM3A overexpression upregulated fibrosis genes (COMP, COL8A1, LOX) and downregulated ACOT1, enhancing cardiac fibrosis and heart failure.

Conclusions:

  • COMP, COL8A1, LOX, and ACOT1 are significantly involved in cardiac fibrosis development.
  • KDM3A plays a critical role in regulating fibrosis-related genes.
  • These genes represent potential biomarkers for heart failure.